Syndromic oculocutaneous albinism
MONDO:0017305A oculocutaneous albinism that is part of a larger syndrome.
Also known as: syndrome associated with oculocutaneous albinism, syndromic oculocutaneous albinism
12 clinical trials for this condition and its sub-types, 0 tagged with Syndromic oculocutaneous albinism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Syndromic oculocutaneous albinism
-
Chediak-Higashi syndrome 9 trials
-
Hermansky-Pudlak syndrome 4 trials
9 sub-types
- Hermansky-Pudlak syndrome with pulmonary fibrosis 0 trials · 1 incl. sub-types Sub-types →
- Hermansky-Pudlak syndrome 10 0 trials
- Hermansky-Pudlak syndrome 11 0 trials
- Hermansky-Pudlak syndrome 2 0 trials
- Hermansky-Pudlak syndrome 7 0 trials
- Hermansky-Pudlak syndrome 8 0 trials
- Hermansky-Pudlak syndrome 9 0 trials
- Hermansky-Pudlak syndrome without pulmonary fibrosis 0 trials Sub-types →
- Kotzot-Richter syndrome 0 trials
-
Griscelli syndrome 2 trials · 3 incl. sub-types
3 sub-types
- Griscelli syndrome type 2 1 trial
- Griscelli syndrome type 1 0 trials
- Griscelli syndrome type 3 0 trials
Most studied deeper sub-types
-
Stem cell transplant offers new hope for kids with rare immune diseases
Disease control OngoingThis study tests a donor stem cell transplant for people with severe immune system problems, like SCID and Wiskott-Aldrich syndrome. The goal is to help the body make healthy blood cells and fight infections. Participants receive donated stem cells to rebuild their immune system.…
Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Milder stem cell transplant shows promise for kids with immune disorders
Disease control OngoingThis study tests a stem cell transplant using a milder chemotherapy-like regimen to treat children and young adults (up to age 28) with various immune system disorders. The goal is to help the donor stem cells settle in the body with fewer side effects. The study involves 20 part…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Scientists dig into tissue samples to unravel lung scarring mystery
Knowledge-focused OngoingThis study collects and analyzes blood, DNA, and tissue samples from 315 adults with pulmonary fibrosis, their relatives, and healthy volunteers. The goal is to learn more about the disease's causes, not to test a new treatment. Researchers hope the findings will guide future the…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC